Filing Details

Accession Number:
0001209191-21-028188
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-23 19:26:10
Reporting Period:
2021-04-21
Accepted Time:
2021-04-23 19:26:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1528287 Neuropace Inc NPCE Surgical & Medical Instruments & Apparatus (3841) 223550230
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1856303 Evan Norton Ugland House
South Church Street, Po Box 309
Grand Cayman E9 KY1-1104
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-21 588,235 $17.00 588,235 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. Reflects shares purchased from the underwriters in the Companys initial public offering.
  2. Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Mr. Norton, a member of our board of directors, is a General Partner at Accelmed LLC. The address of each of Accelmed LLC, Accelmed Partners II GP, LP, Accelmed Partners II LP and Mr. Norton is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.